The risk of chronic liver disease and liver-related mortality is increased in patients with type 2 diabetes mellitus. Several cohort studies have suggested a metabolic pathway from nonalcoholic fatty liver, nonalcoholic steatohepatitis, cryptogenic cirrhosis, and eventually hepatocellular carcinoma. Although cardiovascular risk remains the major cause for excess mortality in type 2 diabetes mellitus, the risk of progressive liver disease should no longer be underscored.
NASH and the risk of cirrhosis and hepatocellular carcinoma in Type 2 diabetes / E. Bugianesi; E. Vanni; G. Marchesini Reggiani. - In: CURRENT DIABETES REPORT. - ISSN 1534-4827. - STAMPA. - 7:(2007), pp. 175-180.
NASH and the risk of cirrhosis and hepatocellular carcinoma in Type 2 diabetes
MARCHESINI REGGIANI, GIULIO
2007
Abstract
The risk of chronic liver disease and liver-related mortality is increased in patients with type 2 diabetes mellitus. Several cohort studies have suggested a metabolic pathway from nonalcoholic fatty liver, nonalcoholic steatohepatitis, cryptogenic cirrhosis, and eventually hepatocellular carcinoma. Although cardiovascular risk remains the major cause for excess mortality in type 2 diabetes mellitus, the risk of progressive liver disease should no longer be underscored.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
